Status:
COMPLETED
Epigallocatechin Gallate and Other Antural Compounds in HPV Infections
Lead Sponsor:
Centro di Ricerca Clinica Salentino
Conditions:
Papilloma-induced Cervical Lesions
Eligibility:
FEMALE
20-45 years
Phase:
PHASE2
Brief Summary
The investigators enroll patients with a PAP-test cytology reporting LSIL or ASCUS. Pateitns undergo HPV-DNA test for screening. Patients are treated with Epigallocatechin galalte, hyaluronic acid, f...
Eligibility Criteria
Inclusion
- Positivity to HPV-DNA test
- PAP-test reporting LSIL or ASCUS
Exclusion
- HPV-related pathologies or complicances apart from LSIL or ASCUS
- Diagnosis of cancer
Key Trial Info
Start Date :
November 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 28 2024
Estimated Enrollment :
178 Patients enrolled
Trial Details
Trial ID
NCT06098456
Start Date
November 1 2023
End Date
June 28 2024
Last Update
July 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ospedale Veris delli Ponti
Scorrano, Lecce, Italy, 73020